AMRI Expands Manufacturing Services in India

Drug discovery and pharmaceutical manufacturing company Albany Molecular Research Inc. (AMRI; Albany, NY) says it has expanded its multi-purpose pilot plant at Aurangabad, India, to provide nonGMP manufacturing services of up to a 1,000 liter scale. The expanded facility will be an extension to AMRI’s Hyderabad, India kilo lab that operates to a 100 liter scale, AMRI says. Some output from the plant will be used as starting materials for AMRI’s U.S. manufacturing facilities, significantly reducing reliance on external resource providers, AMRI says...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers